2016
DOI: 10.1002/cmdc.201600015
|View full text |Cite
|
Sign up to set email alerts
|

Studies on Cycloheptathiophene‐3‐carboxamide Derivatives as Allosteric HIV‐1 Ribonuclease H Inhibitors

Abstract: Despite the significant progress achieved with combination antiretroviral therapy in the fight against human immunodeficiency virus (HIV) infection, the difficulty to eradicate the virus together with the rapid emergence of multidrug-resistant strains clearly underline a pressing need for innovative agents, possibly endowed with novel mechanisms of action. In this context, owing to its essential role in HIV genome replication, the reverse transcriptase associated ribonuclease H (RNase H) has proven to be an ap… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
18
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 18 publications
(19 citation statements)
references
References 52 publications
1
18
0
Order By: Relevance
“…All the reported values represent the means ± SD of data derived from at least three independent experiments in duplicate. d Reported in reference [26].…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…All the reported values represent the means ± SD of data derived from at least three independent experiments in duplicate. d Reported in reference [26].…”
Section: Resultsmentioning
confidence: 99%
“…isopropyl, tert-butyl, cyclohexyl, piperazine, and 2-pyridilpiperazine (12)(13)(14)(15)(16), were also used as C-3 substituents. Methoxy intermediates 17 [26], 18, and 19 (Table 1) were also assayed to enrich the SAR. The replacement of the hydroxyl group at the C-2 phenyl ring was also investigated with the o-amino and p-amino derivatives 20 [26] and 21 [26] (Table 1).…”
Section: Design Of Chtc Analoguesmentioning
confidence: 99%
See 2 more Smart Citations
“…Several classes of compounds have shown promising antiviral activity by acting on RNase H activity including N-hydroxyimides, 42 tropolones, 43,44 hydroxypyridonecarboxylic acids, 25,45,46 diketoacids, 47 vinylogous ureas, 48 and thienopyrimidinones; 49 48,51 as well as cycloheptathiophene-3-carboxamides (cHTC). 52,53 Allosteric binding may exhibit fewer side effects compared to active site Mg 2+ chelating inhibitors and therefore allow for a more favorable therapeutic window. 8, 9…”
Section: Activity Of B#24 Against Hiv-1 Reverse Transcriptasementioning
confidence: 99%